|
|
Volumn 93, Issue 22, 2001, Pages 1680-1681
|
|
Anthrax as a cancer drug?
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTHRAX TOXIN;
ANTIBIOTIC AGENT;
BACTERIAL ANTIGEN;
BACTERIAL PROTEIN;
DRUG;
VACCINE;
ANTHRAX;
ANTINEOPLASTIC ACTIVITY;
BACTERIAL SPORE;
BLOOD VESSEL;
BREAST CANCER;
CANCER GROWTH;
CANCER REGRESSION;
CANCER RESEARCH;
CANCER THERAPY;
CELL SURFACE;
COLON CANCER;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG SYNTHESIS;
HUMAN;
INHIBITION KINETICS;
MACROPHAGE;
MELANOMA;
NOTE;
PRIORITY JOURNAL;
TUMOR CELL DESTRUCTION;
TUMOR VOLUME;
|
|
EID: 0035930083
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/93.22.1680 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|